COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study.

The link between type 2 diabetes (T2D) and the severe outcomes of COVID-19 has raised concerns about the optimal management of patients with T2D. This study aimed to investigate the clinical characteristics and outcomes of T2D patients hospitalized with COVID-19 and explore the potential associations between chronic T2D treatments and adverse outcomes. This was a multicenter prospective cohort study of T2D patients hospitalized with COVID-19 in Greece during the third wave of the pandemic (February-June 2021).

Activin-A impedes the establishment of CD4 T cell exhaustion and enhances anti-tumor immunity in the lung.

Background: Although tumor-infiltrating T cells represent a favorable prognostic marker for cancer patients, the majority of these cells are rendered with an exhausted phenotype. Hence, there is an unmet need to identify factors which can reverse this dysfunctional profile and restore their anti-tumorigenic potential. Activin-A is a pleiotropic cytokine, exerting a broad range of pro- or anti-inflammatory functions in different disease contexts, including allergic and autoimmune disorders and cancer.

ERS International Congress, Madrid, 2019: highlights from the Thoracic Oncology Assembly.

Lung cancer is a devastating disease affecting hundreds of thousands of patients in Europe. Despite recent advances in treatment, its prognosis remains poor. This is mainly attributed to the late stages that diagnoses are usually established at, consequently excluding curative treatment options.

ESR/ERS statement paper on lung cancer screening.

In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now.

ESR/ERS statement paper on lung cancer screening.

In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now.

Continuous professional development: elevating thoracic oncology education in Europe.

http://bit.ly/31ShuTp.

Highlights of thoracic oncology from the 2018 ERS International Congress.

Lung cancer is a substantial global burden for patients, healthcare professionals and healthcare systems. Multiple scientific international and national initiatives are tackling the various problems associated with this disease, which is currently the leading cause of cancer-related mortality worldwide. During the European Respiratory Society International Congress 2018 in Paris, France, lung cancer experts gathered to present the most recent aspects of lung cancer care, and discuss the need for joint initiatives and an international lung cancer alliance, aiming to provide high quality, accessible health care.

Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer.

http://ow.ly/42Wn30m78Zw.

Early Career Members at the ERS International Congress 2017: highlights from the Assemblies.


 http://ow.ly/klLS30gAN49.

Assembly 11: thoracic oncology.

http://ow.ly/6Fhb30js5LE.

Novel therapies for severe asthma in children and adults.

http://ow.ly/UWpg30hImQh.

Early Career Members at the ERS LSC 2017: mechanistic overlap between chronic lung injury and cancer.

http://ow.ly/I3M730fkn5X.

Asbestos and the lung: highlights of a detrimental relationship.

http://ow.ly/EPDa30e8JqK.

Clinical asthma phenotypes in the real world: opportunities and challenges.

Asthma is a common, chronic and heterogeneous syndrome, affecting people of all ages, all races and both sexes. It may range from mild disease with barely noticeable symptoms, to very severe disease with constant symptoms that greatly hinder the life of the patient. Guidelines issued by various medical societies provide guidance on how to diagnose and manage asthmatic patients.

Mediastinal widening and miliary chest radiograph pattern in a middle aged man: could it be sarcoidosis?

A diagnosis of sarcoidosis is based on suggestive radiographic pattern, presence of non-caseating granulomas and negative fungal and acid-fast bacilli (AFB) cultures. Sarcoidosis usually presents with hilar and/or mediastinal lymphadenopathy and distinct parenchymal radiographic patterns, such as fine nodular, reticulonodular or acinar opacities and rarely focal nodules or masses. A diffuse miliary pattern occurs in less than 1% of cases and can be identical to patterns seen in tuberculosis, fungal infections, histiocytosis and miliary metastases.